Wacker inaugurates cystine production in Spain
13 Sep 2018 -- Wacker Biosolutions, the life sciences division of the Wacker Group, has begun producing fermentation-generated cystine at its new site in León, Spain. Over the past eighteen months, the division has extensively modernized part of the 800 m³ fermentation capacity acquired there at the end of 2016. In addition, it has built a production line for cystine. Capital spending for the site totals some €30 million (US$34.8 million). In the next few months, the plants are to be gradually qualified and ramped up to full capacity. The new site enables Wacker to meet its customers’ rising global demand, according to the company. Cystine and cysteine produced from cystine are used in the food and pharmaceutical industries. Wacker currently employs more than 40 people in León. “With our investment in the León site, we are well equipped to further strengthen our position as the global market and technology leader for fermentation-generated cystine,” says Dr. Gerhard Schmid, head of Wacker Biosolutions, explaining the expansion measures. “The modernized fermentation plants and the new cystine production plant enable us to reliably meet our customers’ growing demand for cysteine and cystine, and to commercialize new fermentation-generated products.” Speaking to FoodIngredientsFirst, Christof Bachmair, Senior Manager for Media Relations says: “The main application areas for cystine and cysteine are the pharmaceutical, cosmetics and food sectors. They are used, for example, to manufacture flavorings, to make doughs in baked goods easier to process, and they work as a free-radical scavenger in cosmetics products or as an expectorant in cough medicines.” “Both cystine and cysteine are globally required products and Spain is not the biggest market. From our new León site which we acquired at the end of 2016, we will also supply customers from other countries and regions,” he notes. “As our cysteine is manufactured from purely plant-based and inorganic starting materials, it is entirely vegetarian and meets the rising demand for such vegetarian ingredients. Our production plants in León enable us to reliably meet our customers’ growing demand for cystine and cysteine. For the future, we intend to use part of our fermentation capacities to commercialize new fermentation-generated products,” Bachmair explains. Wacker is the first company in the world to produce cystine by fermentation in a patented biotech process. Due to the entirely plant-based and inorganic raw materials, Wacker cystine and cysteine are purely vegetarian. This makes them safe for use in food and pharmaceutical products. In 2008, Wacker was awarded the Federation of German Industries (BDI) Environmental Prize for its innovative production of cysteine. By Elizabeth Green To contact our editorial team please email us at editorial@cnsmedia.com 
Related ArticlesFood Ingredients News CJ Haide expands cysteine production
28 Nov 2017 --- In January of 2017, CJ Haide (a Subsidiary of CJ CheilJedang) based in Ningbo, China, launched its first fermented cysteine, using an innovative production method. Since its launch, CJ Haide’s cysteine has been enjoying favorable reception from the market, because it offers eco-friendly, vegan product at a very competitive price. By continuing to use non-GMO raw materials, CJ plans to expand its market share by increasing its supply in Q4 of 2017. Food Ingredients News Wacker expands production and R&D capacities in China
10 Nov 2017 --- Wacker Chemie AG is set to expand its production capacities in China and continue to reinforce its research and development capability in order to further strengthen its market position in the region. Food Ingredients News Special Report: Alternative Proteins Trending – Plant, Insects and Marine Sources
21 Feb 2017 --- Demand for plant-based ingredients like algae, spirulina, seaweed, duckweed, pea proteins is climbing, as the appetite for pulses, non dairy or meat-free alternatives increases - even insects are getting in on the alternative protein scene. Interestingly the consumption of fresh fruit and vegetables is in a ten year decline with no real progress made in Europe, the US or elsewhere despite massive health campaigns pushing for everyone, kids especially, to eat more of the good stuff. Food Ingredients News CJ CheilJedang Launches Fermented L-Cysteine Through Sustainable Technology
17 Jan 2017 --- CJ CheilJedang has announced the launch of l-cysteine and its derivatives produced through the use of an environmentally-friendly fermentation technology. According to the company, the technology uses raw sugar and glucose as a raw material, while the majority of manufacturers in the market are using a hydrolysis process that starts with duck feather as a raw material. Business News WACKER to Expand Production of Cysteine Following Spanish Fermentation Plant Acquisition
20 Dec 2016 --- WACKER BIOSOLUTIONS, the life sciences and biotechnology division of the WACKER Group, is acquiring a large-scale fermentation plant from Antibióticosde León SLU (ADL) in Spain. Today, the two companies have announced the signing of the contract of sale. At the León plant, WACKER will produce cysteine by fermentation for use in food and pharmaceutical products. For WACKER, this strategic acquisition is a major step in satisfying globally growing customer demand for cysteine during the years ahead, and in supporting the commercialization of other bioengineered products. |
